Include Sublocade for Opioid Use Disorder in Patient Profiles

March 2018

Sublocade (SUB-loh-kayd) will be the first once-monthly buprenorphine INJECTION for opioid use disorder.

Expect Sublocade to be saved for patients who are stable on a sublingual or buccal buprenorphine-containing product (Suboxone, etc) for at least a week...at doses equivalent to 8 to 24 mg/day.

Be aware that Sublocade will be available through certain specialty pharmacies...and it must be administered by a healthcare provider. Plus it costs $1,600/month.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Poison Prevention Use National Poison Prevention Week as a Chance to Raise Awareness
Medicare Update Patient Profiles With New Medicare Card Numbers
Electrolytes Watch for Various Salt Forms of Electrolytes
Anticoagulants Bevyxxa Will Join Other Anticoagulant Meds on Your Shelf
Influenza Anticipate Questions About Supplements for Influenza
Vaccines Expect Some Patients to Get MMR Boosters During a Mumps Outbreak
Med Adherence Work as a Team to Help Patients Stick With Their Meds
Hyperglycemia Listen for Signs of High Blood Sugar in Diabetes Patients Taking a Steroid
Substance Use Disorder Include Sublocade for Opioid Use Disorder in Patient Profiles
Obesity & Weight Loss Be Prepared to Handle Med Changes After Bariatric Surgery
Privacy & HIPAA Remember "When in Doubt, Use the Shred Route" With Patient Information

Include Sublocade for Opioid Use Disorder in Patient Profiles

Practical advice for a better career, with unlimited access to CE

Table of Contents